Pharmacy Times

JULY 7, 2025

Takeda will discontinue Gammagard S/D by December 2027, transitioning to the new low IgA formulation. Takeda has informed the FDA that the manufacturing of Gammagard S/D will cease in December 2027.

Pharmacy Technician 39

Pharmacy Technician Immunization Immunity Compounding Pharmacies 39

Express Pharma

NOVEMBER 26, 2024

Spanning pharma machinery, packaging, analytical instruments, laboratory technologies, ingredients, and beyond, it offers a comprehensive platform for stakeholders to engage in transformative dialogues and foster strategic partnerships. With exports nearing $27.84 Adam Anderson , Executive VP – Pharma, Informa Markets B.V

Packaging 105

Packaging Biosimilars Pharmaceutical Manufacturing Dosage 105

European Pharmaceutical Review

FEBRUARY 22, 2023

1 Used to treat a range of chronic diseases (eg, diabetes, rheumatoid arthritis, psoriasis, Crohn’s disease, haemophilia, etc), it is projected that the sales of biologics will rise from $380 billion in 2022 to $416 billion in 2023, and to almost $600 billion in 2027. the enteric coating and the capsule dissolve.

Biosimilars 105

Biosimilars Diabetes Immunization Immunity 105

pharmaphorum

FEBRUARY 3, 2022

reaching £915 billion by 2027. Delve into the world of biologics and biosimilars and what these mean for the injectable drug market. The injectable drug delivery market is expected to rise at a compound annual growth rate of 12.9% Develop your understanding of high-volume and long-acting injectable compounds. Device Engineering.

Compounding 52

Compounding Packaging Biosimilars Vaccines 52

FDA Law Blog: Biosimilars

JULY 10, 2025

Texas Goes BIG on Food Warnings Beginning on January 1, 2027, Texans may notice new warning labels on some food products sold in their fair state. This labeling requirement will apply to packages “developed or copyrighted” from January 1, 2027 onward. Here’s what industry needs to know. Preservatives such as BHA and BHT.

Labelling 66

Labelling Packaging Communication 66